Physiologically based pharmacokinetic modeling and simulation in pediatric drug development

163Citations
Citations of this article
197Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Increased regulatory demands for pediatric drug development research have fostered interest in the use of modeling and simulation among industry and academia. Physiologically based pharmacokinetic (PBPK) modeling offers a unique modality to incorporate multiple levels of information to estimate age-specific pharmacokinetics. This tutorial will serve to provide the reader with a basic understanding of the procedural steps to developing a pediatric PBPK model and facilitate a discussion of the advantages and limitations of this modeling technique.

Cite

CITATION STYLE

APA

Maharaj, A. R., & Edginton, A. N. (2014). Physiologically based pharmacokinetic modeling and simulation in pediatric drug development. CPT: Pharmacometrics and Systems Pharmacology, 3(11). https://doi.org/10.1038/psp.2014.45

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free